Literature DB >> 9916106

Characterization of a WaaF (RfaF) homolog expressed by Haemophilus ducreyi.

B A Bauer1, S R Lumbley, E J Hansen.   

Abstract

Haemophilus ducreyi lipooligosaccharide (LOS) is capable of inducing an inflammatory response in skin (A. A. Campagnari, L. M. Wild, G. Griffiths, R. J. Karalus, M. A. Wirth, and S. M. Spinola, Infect. Immun. 59:2601-2608, 1991) and likely contributes to the virulence of this sexually transmitted pathogen (B. A. Bauer, M. K. Stevens, and E. J. Hansen, Infect. Immun. 68:4290-4298, 1998). An open reading frame in H. ducreyi 35000 was found to encode a predicted protein that was 59% identical to the protein product of the rfaF (waaF) gene of Salmonella typhimurium. The H. ducreyi waaF gene was able to complement an S. typhimurium rfaF (waaF) mutant, a result which confirmed the identity of this gene. In contrast to the rfaF (waaF) gene of enteric bacteria, the H. ducreyi waaF gene was not located adjacent to other genes involved in lipopolysaccharide expression. Inactivation of the H. ducreyi waaF gene by insertion mutagenesis resulted in expression of a LOS that migrated much faster than wild-type LOS in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The LOS of this mutant also did not bind a monoclonal antibody directed against a cell surface-exposed epitope of wild-type H. ducreyi LOS. Testing of the wild-type H. ducreyi strain and its isogenic waaF mutant in the temperature-dependent rabbit model for dermal lesion production by H. ducreyi revealed that this waaF mutant was less virulent than the wild-type parent strain. Complementation of the H. ducreyi waaF mutant with the wild-type H. ducreyi waaF gene resulted in expression of both wild-type LOS and wild-type virulence by this mutant.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916106      PMCID: PMC96402     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  78 in total

1.  The polymerase chain reaction. History, methods, and applications.

Authors:  N S Templeton
Journal:  Diagn Mol Pathol       Date:  1992-03

2.  Use of electroporation to construct isogenic mutants of Haemophilus ducreyi.

Authors:  E J Hansen; J L Latimer; S E Thomas; M Helminen; W L Albritton; J D Radolf
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

3.  Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens.

Authors:  A A Campagnari; S M Spinola; A J Lesse; Y A Kwaik; R E Mandrell; M A Apicella
Journal:  Microb Pathog       Date:  1990-05       Impact factor: 3.738

4.  Comparison of lipopolysaccharide biosynthesis genes rfaK, rfaL, rfaY, and rfaZ of Escherichia coli K-12 and Salmonella typhimurium.

Authors:  J D Klena; E Pradel; C A Schnaitman
Journal:  J Bacteriol       Date:  1992-07       Impact factor: 3.490

5.  Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated.

Authors:  R E Mandrell; R McLaughlin; Y Aba Kwaik; A Lesse; R Yamasaki; B Gibson; S M Spinola; M A Apicella
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

6.  A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi.

Authors:  B K Purcell; J A Richardson; J D Radolf; E J Hansen
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

7.  Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi.

Authors:  A A Campagnari; L M Wild; G E Griffiths; R J Karalus; M A Wirth; S M Spinola
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  Cloning, characterization, and DNA base sequence of the high-level streptomycin resistance gene strA1 of Haemophilus influenzae Rd.

Authors:  J H Stuy; R B Walter
Journal:  J Bacteriol       Date:  1992-09       Impact factor: 3.490

9.  Mouse subcutaneous chamber model for in vivo growth of Haemophilus ducreyi.

Authors:  D L Trees; R J Arko; S A Morse
Journal:  Microb Pathog       Date:  1991-11       Impact factor: 3.738

10.  Analysis of the lsi region involved in lipooligosaccharide biosynthesis in Neisseria gonorrhoeae.

Authors:  E F Petricoin; R J Danaher; D C Stein
Journal:  J Bacteriol       Date:  1991-12       Impact factor: 3.490

View more
  9 in total

Review 1.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  A deep-rough mutant of Campylobacter jejuni 81-176 is noninvasive for intestinal epithelial cells.

Authors:  Margaret I Kanipes; Lindsay C Holder; Adrian T Corcoran; Anthony P Moran; Patricia Guerry
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  Characterization of the Campylobacter jejuni heptosyltransferase II gene, waaF, provides genetic evidence that extracellular polysaccharide is lipid A core independent.

Authors:  Neil J Oldfield; Anthony P Moran; Lorna A Millar; Martina M Prendergast; Julian M Ketley
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

4.  Identification of genes involved in the expression of atypical lipooligosaccharide structures from a second class of Haemophilus ducreyi.

Authors:  Deborah M B Post; Robert S Munson; Beth Baker; Huachun Zhong; Joel A Bozue; Bradford W Gibson
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

5.  Haemophilus ducreyi Outer membrane determinants, including DsrA, define two clonal populations.

Authors:  Catherine Dinitra White; Isabelle Leduc; Bonnie Olsen; Chrystina Jeter; Chavala Harris; Christopher Elkins
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers.

Authors:  R S Young; K Fortney; J C Haley; A F Hood; A A Campagnari; J Wang; J A Bozue; R S Munson; S M Spinola
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

7.  Construction and characterization of Haemophilus ducreyi lipooligosaccharide (LOS) mutants defective in expression of heptosyltransferase III and beta1,4-glucosyltransferase: identification of LOS glycoforms containing lactosamine repeats.

Authors:  M J Filiatrault; B W Gibson; B Schilling; S Sun; R S Munson; A A Campagnari
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Haemophilus ducreyi lipooligosaccharide mutant defective in expression of beta-1,4-glucosyltransferase is virulent in humans.

Authors:  R S Young; M J Filiatrault; K R Fortney; A F Hood; B P Katz; R S Munson; A A Campagnari; S M Spinola
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  Development of a rapid immunodiagnostic test for Haemophilus ducreyi.

Authors:  Kristine Patterson; Bonnie Olsen; Christopher Thomas; Dora Norn; Milton Tam; Christopher Elkins
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.